These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11102742)

  • 1. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Br J Pharmacol; 2000 Jul; 130(5):1037-44. PubMed ID: 10882388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat.
    Cleton A; de Greef HJ; Edelbroek PM; Voskuyl RA; Danhof M
    J Pharmacokinet Biopharm; 1999 Jun; 27(3):301-23. PubMed ID: 10728492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat.
    Cleton A; de Greef HJ; Edelbroek PM; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 Dec; 128(8):1651-8. PubMed ID: 10588919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
    Halonen T; Nissinen J; Jansen JA; Pitkänen A
    Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats.
    Coenen AM; Blezer EH; van Luijtelaar EL
    Epilepsy Res; 1995 Jun; 21(2):89-94. PubMed ID: 7588592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat.
    Lancel M; Faulhaber J; Deisz RA
    Br J Pharmacol; 1998 Apr; 123(7):1471-7. PubMed ID: 9579745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of γ-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and γ-Aminobutyric acid metabolism in the anesthetized rat In vivo.
    Patel AB; de Graaf RA; Rothman DL; Behar KL
    J Neurosci Res; 2015 Jul; 93(7):1101-8. PubMed ID: 25663257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.
    Fink-Jensen A; Suzdak PD; Swedberg MD; Judge ME; Hansen L; Nielsen PG
    Eur J Pharmacol; 1992 Sep; 220(2-3):197-201. PubMed ID: 1425991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
    Smith SE; Parvez NS; Chapman AG; Meldrum BS
    Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat.
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2004 May; 45(5):424-35. PubMed ID: 15101823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
    Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C
    Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiagabine.
    Mengel H
    Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis.
    Ipponi A; Lamberti C; Medica A; Bartolini A; Malmberg-Aiello P
    Eur J Pharmacol; 1999 Mar; 368(2-3):205-11. PubMed ID: 10193656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolateral thalamus.
    Richards DA; Bowery NG
    Neurochem Res; 1996 Feb; 21(2):135-40. PubMed ID: 9182238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
    Walton NY; Gunawan S; Treiman DM
    Epilepsy Res; 1994 Dec; 19(3):237-44. PubMed ID: 7698100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.